QQ客服 官方微博 反馈留言

	Efficacy and safety of capecitabine plus oxaliplatin (XELOX) as the perioperative treatment of patients with potentially resectable liver-only metastases from colorectal cancer: A single arm, open-label, multicenter phase II trial (ML22298; NCT00997685)
	Lin F., Li G., Chu Z., Hao C., Chen M., Jiang Z., Chen H., Lin J., Li D., Hu B., Wang X.
刊名	Journal of Clinical Oncology
	2015
卷号	33
ISSN号	0732-183X
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3435247
专题	昆明医科大学
推荐引用方式 GB/T 7714	Lin F., Li G., Chu Z., Hao C., Chen M., Jiang Z., Chen H., Lin J., Li D., Hu B., Wang X.. Efficacy and safety of capecitabine plus oxaliplatin (XELOX) as the perioperative treatment of patients with potentially resectable liver-only metastases from colorectal cancer: A single arm, open-label, multicenter phase II trial (ML22298; NCT00997685)[J]. Journal of Clinical Oncology,2015,33.
APA	Lin F., Li G., Chu Z., Hao C., Chen M., Jiang Z., Chen H., Lin J., Li D., Hu B., Wang X..(2015).Efficacy and safety of capecitabine plus oxaliplatin (XELOX) as the perioperative treatment of patients with potentially resectable liver-only metastases from colorectal cancer: A single arm, open-label, multicenter phase II trial (ML22298; NCT00997685).Journal of Clinical Oncology,33.
MLA	Lin F., Li G., Chu Z., Hao C., Chen M., Jiang Z., Chen H., Lin J., Li D., Hu B., Wang X.."Efficacy and safety of capecitabine plus oxaliplatin (XELOX) as the perioperative treatment of patients with potentially resectable liver-only metastases from colorectal cancer: A single arm, open-label, multicenter phase II trial (ML22298; NCT00997685)".Journal of Clinical Oncology 33(2015).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。